CELLINK
LIVE

Serial Number

87753836

Owner

CELLINK AB

Attorney

Margarita Wallach,

Filing Date

Jan 12, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CELLINK Trademark

Serial Number: 87753836 • Registration: 6121600

CELLINK is a trademark filed by CELLINK AB on January 12, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CELLINK AB (30 trademarks)

ARVID WALLGRENS BACKE 20
GOTHENBURG 41346 , SE

Entity Type: 03

CELLINK Bioprinting AB (23 trademarks)

LÃ¥ngfilsgatan 5

Entity Type: 98

Trademark Details

Filing Date

January 12, 2018

Registration Date

August 11, 2020

Published for Opposition

May 26, 2020

Goods & Services

3D printing services; Renting of 3D printers; Creation of customised three-dimensional shaped parts using rapid prototyping equipment; 3D Bioprinting; Bioprinting

Laboratory devices that can be used in biotechnology, and the pharmaceuticals and cosmetics industries for computer-assisted, three-dimensional dosing of biomaterials for the patient-friendly, biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and releasing systems for medicinal substances; Laboratory apparatus for fabrication of three dimensional (3D) living tissues

Three-dimensional printers (3D printers); Three-dimensional bioprinters (3D bioprinters); Computer controlled 3D printers for the generation of three-dimensional shaped parts; Machines for manufacturing three dimensional models, namely, computer-aided modeling devices; computer-aided additive machines for manufacturing three-dimensional objects; machines for manufacturing three dimensional models, namely, computer-aided modeling devices and associated computer hardware and software sold as a unit; computer-aided additive machines for manufacturing three-dimensional objects and associated computer hardware and software sold as a unit; Machines for manufacturing three dimensional (3D) living tissues; machines, namely, three dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing 3D printing material sold empty; cartridges for containing 3D bioprinting material sold empty; 3D printing cartridges for containing biomaterial sold empty; 3D printing cartridges for containing bioink sold empty

Biological tissue cultures for medical purposes; Tissue-regenerative pharmaceutical preparations

Biologically compatible materials, namely, hydrogels used to create structures and scaffolds used in the manufacture of living tissue; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Biological tissue specimens for use in scientific research; Cellulose nanofibril based biological preparations for use in 3d bioprinting of tissues and organs

Devices that can be used in medicine for computer-assisted, three-dimensional dosing of biomaterials for the patient-friendly, biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and releasing systems for medicinal substances

Research and development of 3D technology and processes; Development of rapid prototyping equipment; Technical consultancy relating to rapid prototyping development and research; Scientific research consulting in the fields of three-dimensional printing; Scientific services relating to the isolation and cultivation of human tissues and cells

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 11, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 15, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2020 NONP
EXPARTE APPEAL TERMINATED
Apr 16, 2020 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2020 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 12, 2020 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jun 21, 2019 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jun 21, 2019 GECD
ACTION CONTINUING FINAL - COMPLETED
Jun 21, 2019 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2019 CRFA
ASSIGNED TO LIE
May 21, 2019 ALIE
EX PARTE APPEAL-INSTITUTED
May 15, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 15, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 15, 2019 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 14, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 14, 2018 GNFN
FINAL REFUSAL E-MAILED
Nov 14, 2018 GNFR
FINAL REFUSAL WRITTEN
Nov 14, 2018 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 9, 2018 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 9, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 9, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 9, 2018 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2018 NWOS
NEW APPLICATION ENTERED
Jan 16, 2018 NWAP